Methylmalonic Acid in Amniotic Fluid and Maternal Urine as a Marker for Neural Tube Defects

To evaluate the implication of methymalonic acid (MMA) in the early diagnosis of neural tube defects (NTD), a quantitative assay for MMA was established by using gas chromatography-mass spectrometry with stable isotope of MMA as an internal standard. Amniotic fluid and maternal urine MMA concentrati...

Full description

Saved in:
Bibliographic Details
Published inCurrent medical science Vol. 24; no. 2; pp. 166 - 169
Main Author 罗小平 张炼 魏红 刘皖君 王慕逖 宁琴
Format Journal Article
LanguageEnglish
Published China Department of Pediatrics, Tongji Hospital, Center for the Diagnosis of Genetic Metabolic Diseases, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030,China 2004
Subjects
Online AccessGet full text
ISSN1672-0733
2096-5230
1993-1352
2523-899X
DOI10.1007/BF02885420

Cover

Loading…
Abstract To evaluate the implication of methymalonic acid (MMA) in the early diagnosis of neural tube defects (NTD), a quantitative assay for MMA was established by using gas chromatography-mass spectrometry with stable isotope of MMA as an internal standard. Amniotic fluid and maternal urine MMA concentration, maternal serum folate, red blood cell folate and vitamin B12 levels were measured in the middle term of NTD-affected and normal pregnancies. Amniotic fluid and maternal urine MMA concentrations in the middle term of NTD affected pregnancies (1.4±0.9 μmol/L, and 22.1±12.6 nmol/μmol creatinine) were significantly higher than that of normal pregnancies(1.0±0.4μmol/L, and 2.5±1.1 nmol/μmol creatinine). There was no significant difference be-tween normal and NTD pregnancies for serum folate, red blood cell folate and vitamin B12 levels.The results suggested that MMAs in amniotic fluid and maternal urine are sensitive markers for early diagnosis of NTD. Vitamin B12 is an active cofactor involved in the remethylation of homocycteine and its deficiency is an independent risk factor for NTD. MMA is a specific and sensitive marker for intracellular vitamin B12 deficiency. This study suggests that it is necessary to monitor the vitamin B12 deficiency and advocates vitamin B12 supplementation with folate prevention program.
AbstractList To evaluate the implication of methymalonic acid (MMA) in the early diagnosis of neural tube defects (NTD), a quantitative assay for MMA was established by using gas chromatography-mass spectrometry with stable isotope of MMA as an internal standard. Amniotic fluid and maternal urine MMA concentration, maternal serum folate, red blood cell folate and vitamin B12 levels were measured in the middle term of NTD-affected and normal pregnancies. Amniotic fluid and maternal urine MMA concentrations in the middle term of NTD affected pregnancies (1.4 +/- 0.9 micromol/L, and 22.1 +/- 12.6 nmol/micromol creatinine) were significantly higher than that of normal pregnancies (1.0 +/- 0. 4 micromol/L, and 2.5 +/- 1.1 nmol/micromol creatinine). There was no significant difference between normal and NTD pregnancies for serum folate, red blood cell folate and vitamin B12 levels. The results suggested that MMAs in amniotic fluid and maternal urine are sensitive markers for early diagnosis of NTD. Vitamin B12 is an active cofactor involved in the remethylation of homocycteine and its deficiency is an independent risk factor for NTD. MMA is a specific and sensitive marker for intracellular vitamin B12 deficiency. This study suggests that it is necessary to monitor the vitamin B12 deficiency and advocates vitamin B12 supplementation with folate prevention program.To evaluate the implication of methymalonic acid (MMA) in the early diagnosis of neural tube defects (NTD), a quantitative assay for MMA was established by using gas chromatography-mass spectrometry with stable isotope of MMA as an internal standard. Amniotic fluid and maternal urine MMA concentration, maternal serum folate, red blood cell folate and vitamin B12 levels were measured in the middle term of NTD-affected and normal pregnancies. Amniotic fluid and maternal urine MMA concentrations in the middle term of NTD affected pregnancies (1.4 +/- 0.9 micromol/L, and 22.1 +/- 12.6 nmol/micromol creatinine) were significantly higher than that of normal pregnancies (1.0 +/- 0. 4 micromol/L, and 2.5 +/- 1.1 nmol/micromol creatinine). There was no significant difference between normal and NTD pregnancies for serum folate, red blood cell folate and vitamin B12 levels. The results suggested that MMAs in amniotic fluid and maternal urine are sensitive markers for early diagnosis of NTD. Vitamin B12 is an active cofactor involved in the remethylation of homocycteine and its deficiency is an independent risk factor for NTD. MMA is a specific and sensitive marker for intracellular vitamin B12 deficiency. This study suggests that it is necessary to monitor the vitamin B12 deficiency and advocates vitamin B12 supplementation with folate prevention program.
To evaluate the implication of methymalonic acid (MMA) in the early diagnosis of neural tube defects (NTD), a quantitative assay for MMA was established by using gas chromatography-mass spectrometry with stable isotope of MMA as an internal standard. Amniotic fluid and maternal urine MMA concentration, maternal serum folate, red blood cell folate and vitamin B12 levels were measured in the middle term of NTD-affected and normal pregnancies. Amniotic fluid and maternal urine MMA concentrations in the middle term of NTD affected pregnancies (1.4 +/- 0.9 micromol/L, and 22.1 +/- 12.6 nmol/micromol creatinine) were significantly higher than that of normal pregnancies (1.0 +/- 0. 4 micromol/L, and 2.5 +/- 1.1 nmol/micromol creatinine). There was no significant difference between normal and NTD pregnancies for serum folate, red blood cell folate and vitamin B12 levels. The results suggested that MMAs in amniotic fluid and maternal urine are sensitive markers for early diagnosis of NTD. Vitamin B12 is an active cofactor involved in the remethylation of homocycteine and its deficiency is an independent risk factor for NTD. MMA is a specific and sensitive marker for intracellular vitamin B12 deficiency. This study suggests that it is necessary to monitor the vitamin B12 deficiency and advocates vitamin B12 supplementation with folate prevention program.
R318; To evaluate the implication of methymalonic acid (MMA) in the early diagnosis of neural tube defects (NTD), a quantitative assay for MMA was established by using gas chromatographymass spectrometry with stable isotope of MMA as an internal standard. Amniotic fluid and maternal urine MMA concentration, maternal serum folate, red blood cell folate and vitamin B12 levels were measured in the middle term of NTD-affected and normal pregnancies. Amniotic fluid and maternal urine MMA concentrations in the middle term of NTD affected pregnancies (1.4 ± 0.9 μmol/L, and 22.1 ± 12.6 nmol/μmol creatinine) were significantly higher than that of normal pregnancies (1.0±0.4μ mol/L, and 2.5± 1.1 nmol/μmol creatinine). There was no significant difference between normal and NTD pregnancies for serum folate, red blood cell folate and vitamin B12 levels.The results suggested that MMAs in amniotic fluid and maternal urine are sensitive markers for early diagnosis of NTD. Vitamin B12 is an active cofactor involved in the remethylation of homocycteine and its deficiency is an independent risk factor for NTD. MMA is a specific and sensitive marker for intracellular vitamin B12 deficiency. This study suggests that it is necessary to monitor the vitamin B12 deficiency and advocates vitamin B12 supplementation with folate prevention program.
To evaluate the implication of methymalonic acid (MMA) in the early diagnosis of neural tube defects (NTD), a quantitative assay for MMA was established by using gas chromatography-mass spectrometry with stable isotope of MMA as an internal standard. Amniotic fluid and maternal urine MMA concentration, maternal serum folate, red blood cell folate and vitamin B12 levels were measured in the middle term of NTD-affected and normal pregnancies. Amniotic fluid and maternal urine MMA concentrations in the middle term of NTD affected pregnancies (1.4±0.9 μmol/L, and 22.1±12.6 nmol/μmol creatinine) were significantly higher than that of normal pregnancies(1.0±0.4μmol/L, and 2.5±1.1 nmol/μmol creatinine). There was no significant difference be-tween normal and NTD pregnancies for serum folate, red blood cell folate and vitamin B12 levels.The results suggested that MMAs in amniotic fluid and maternal urine are sensitive markers for early diagnosis of NTD. Vitamin B12 is an active cofactor involved in the remethylation of homocycteine and its deficiency is an independent risk factor for NTD. MMA is a specific and sensitive marker for intracellular vitamin B12 deficiency. This study suggests that it is necessary to monitor the vitamin B12 deficiency and advocates vitamin B12 supplementation with folate prevention program.
Author 罗小平 张炼 魏红 刘皖君 王慕逖 宁琴
AuthorAffiliation DepartmentofPediatrics,TongjiHospital,CenterfortheDiagnosisofGeneticMetabolicDiseases,TongjiMedicalCollege,HuazhongUniversityofScienceandTechnology,Wuhan430030,China
AuthorAffiliation_xml – name: Department of Pediatrics, Tongji Hospital, Center for the Diagnosis of Genetic Metabolic Diseases, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030,China
Author_xml – sequence: 1
  fullname: 罗小平 张炼 魏红 刘皖君 王慕逖 宁琴
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15315171$$D View this record in MEDLINE/PubMed
BookMark eNptkU1v1DAQhi1URD_gwg9A5sIBFPBXYue4LV2o1MKlPXGwHGfcejexWzsR3X9fV7stEuppRu88M5qZ9xDthRgAofeUfKWEyG_HS8KUqgUjr9ABbVteUV6zvZI3klVEcr6PDnNeEVLLhok3aJ_WnNZU0gP05wKmm80wmiEGb_HC-h77gBdj8HEqwnKYi2JCjy_MBCmYAV8lHwCbjE3R0hoSdjHhXzCnUrycO8DfwYGd8lv02pkhw7tdPEJXy9PLk5_V-e8fZyeL88rSlsmKKUadEEJCDa2gvbBOqLZj0imQjgDvVWctpaImSvDegu0M4coq4kB0PeVH6Mt27l8TnAnXehXnx02znlabdX9_32lghAjCCJWF_rSlb1O8myFPevTZwjCYAHHOumlky0RLCvhhB87dCL2-TX40aaOfnlcAsgVsijkncNr6yUw-hikZP2hK9KM_-p8_peXzfy3PU1-CP-7gmxiu73y5rDN27fwAupWiUarlDxQumJA
CitedBy_id crossref_primary_10_1111_jog_13751
crossref_primary_10_1016_j_jchromb_2011_03_039
crossref_primary_10_1111_cge_14087
crossref_primary_10_3109_14767058_2011_580800
Cites_doi 10.1002/ajmg.1509
10.1002/1096-8628(20001127)95:3<216::AID-AJMG6>3.0.CO;2-F
10.1016/0140-6736(91)90133-A
10.1016/S0301-2115(00)00426-7
10.5858/2001-125-0824-MA
10.1055/s-2007-993975
10.1002/(SICI)1096-9926(199702)55:2<134::AID-TERA3>3.0.CO;2-3
10.1046/j.1365-2796.2001.00819.x
10.1542/peds.106.4.677
10.1093/hmg/5.12.1851
10.1002/(SICI)1097-0223(199806)18:6<545::AID-PD293>3.0.CO;2-2
10.1002/(SICI)1096-8628(19971212)73:2<113::AID-AJMG2>3.0.CO;2-V
10.1016/S0140-6736(80)90886-7
10.1016/S0140-6736(01)05969-4
ClassificationCodes R318
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1007/BF02885420
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1993-1352
2523-899X
EndPage 169
ExternalDocumentID tjykdxxb_e200402017
15315171
10_1007_BF02885420
9746889
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: 国家自然科学基金; the Clinical Key Subjects from the Ministry of Health of China
  funderid: (30125019); (970240)
GroupedDBID -5E
-5G
-BR
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29K
29~
2B.
2C~
2J2
2JN
2KG
2KM
2LR
2RA
2~H
30V
4.4
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
92F
92I
92L
95-
95.
95~
96X
AAAVM
AABHQ
AAJKR
AANXM
AARHV
AARTL
AAYIU
AAYQN
AAYTO
ABFTV
ABJOX
ABKCH
ABMNI
ABNWP
ABQBU
ABTMW
ACGFS
ACHXU
ACKNC
ACOMO
ACSNA
ACUDM
ADHIR
ADINQ
ADKPE
ADURQ
ADYFF
ADZKW
AEBTG
AEGNC
AEJHL
AEKMD
AEOHA
AEPYU
AETLH
AEXYK
AFWTZ
AFZKB
AGAYW
AGDGC
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIIXL
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
ARMRJ
AZFZN
B-.
BA0
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
D-I
EBS
EJD
ESBYG
FA0
FEDTE
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GQ6
GQ7
H13
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IPNFZ
IXD
I~X
I~Z
J-C
JBSCW
JUIAU
KOV
M4Y
MA-
N2Q
NDZJH
NQJWS
NU0
O9-
O93
O9I
O9J
P9S
PF0
QOR
QOS
R-E
R89
R9I
RIG
ROL
RPX
RSV
S..
S16
S1Z
S27
S37
S3B
SAP
SCL
SDH
SHX
SMD
SNE
SNX
SOJ
SPISZ
SZ9
SZN
T13
TCJ
TGQ
TSG
TT1
TUC
U2A
U9L
UG4
VC2
W48
W91
WK8
Z7U
Z82
Z8V
ZOVNA
~A9
~WA
-05
-0E
-SE
-S~
2JY
406
5VR
92M
9D9
9DE
AACDK
AAHNG
AAIAL
AAJBT
AANZL
AAPKM
AASML
AATNV
AAUYE
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABDZT
ABECU
ABFSG
ABHQN
ABJNI
ABKZE
ABMQK
ABSXP
ABTEG
ABTKH
ABWNU
ABXPI
ACAOD
ACDTI
ACHSB
ACMDZ
ACMLO
ACOKC
ACSTC
ACZOJ
ADKNI
ADRFC
ADTPH
AEFQL
AEJRE
AEMSY
AESKC
AEVLU
AEZWR
AFBBN
AFDZB
AFHIU
AFLOW
AFOHR
AFQWF
AFUIB
AGJBK
AGMZJ
AGQEE
AGRTI
AHPBZ
AHSBF
AHWEU
AIAKS
AIGIU
AILAN
AITGF
AIXLP
AMXSW
AMYLF
AMYQR
AOCGG
ATHPR
AXYYD
AYFIA
BDATZ
CAJEE
CITATION
DDRTE
DNIVK
DPUIP
EBLON
EIOEI
FERAY
FFXSO
FIGPU
FINBP
FSGXE
GNWQR
GRRUI
IKXTQ
IWAJR
JZLTJ
LLZTM
NPVJJ
PT4
Q--
RHV
RT5
SCLPG
SDE
SISQX
SJYHP
SNPRN
SOHCF
SRMVM
SSLCW
STPWE
T8U
U1F
U1G
U5E
U5O
UOJIU
UTJUX
UZXMN
VFIZW
YLTOR
ZMTXR
ABQSL
ADHKG
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AGQPQ
4A8
93N
PSX
ID FETCH-LOGICAL-c1927-2821f4447e5e941d4cf489b27f8e7f0e3d8bcc11450843dcecba038c80fe4bd13
ISSN 1672-0733
2096-5230
IngestDate Thu May 29 04:06:47 EDT 2025
Fri Jul 11 08:10:33 EDT 2025
Thu Apr 03 07:08:33 EDT 2025
Tue Jul 01 04:14:36 EDT 2025
Thu Apr 24 22:59:46 EDT 2025
Thu Nov 24 20:35:00 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords neural tube defects
vitamin B12
folic acid
methymalonic acid
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1927-2821f4447e5e941d4cf489b27f8e7f0e3d8bcc11450843dcecba038c80fe4bd13
Notes R714.53
R446.12
42-1679/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15315171
PQID 66792490
PQPubID 23479
PageCount 4
ParticipantIDs wanfang_journals_tjykdxxb_e200402017
proquest_miscellaneous_66792490
pubmed_primary_15315171
crossref_citationtrail_10_1007_BF02885420
crossref_primary_10_1007_BF02885420
chongqing_backfile_9746889
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004-00-00
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – year: 2004
  text: 2004-00-00
PublicationDecade 2000
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Current medical science
PublicationTitleAlternate Journal of Zuazhong University of Science and Technology: Medical Edition
PublicationTitle_FL JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY(MEDICAL SCIENCES)
PublicationYear 2004
Publisher Department of Pediatrics, Tongji Hospital, Center for the Diagnosis of Genetic Metabolic Diseases, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030,China
Publisher_xml – name: Department of Pediatrics, Tongji Hospital, Center for the Diagnosis of Genetic Metabolic Diseases, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030,China
References K Björkegren (BF02885420_CR15) 2001; 249
Y N Li (BF02885420_CR14) 1996; 5
R E Stevenson (BF02885420_CR8) 2000; 106
L I Al-Gazali (BF02885420_CR4) 2001; 103
P De Marco (BF02885420_CR5) 2000; 95
R J Elin (BF02885420_CR7) 2001; 125
R W Smithells (BF02885420_CR9) 1980; 1
C A Moore (BF02885420_CR2) 1997; 73
M T Steen (BF02885420_CR6) 1998; 18
MRC Vitamin Study Research Group (BF02885420_CR10) 1991; 338
J Gindler (BF02885420_CR12) 2001; 358
Committee on Genetics (BF02885420_CR3) 1999; 104
M C Cornel (BF02885420_CR11) 1997; 55
E B Dawson (BF02885420_CR13) 1998; 15
N M J van der Put (BF02885420_CR1) 2000; 92
References_xml – volume: 103
  start-page: 128
  year: 2001
  ident: BF02885420_CR4
  publication-title: Am J Med Genet
  doi: 10.1002/ajmg.1509
– volume: 95
  start-page: 216
  year: 2000
  ident: BF02885420_CR5
  publication-title: Am J Med Genet
  doi: 10.1002/1096-8628(20001127)95:3<216::AID-AJMG6>3.0.CO;2-F
– volume: 338
  start-page: 131
  year: 1991
  ident: BF02885420_CR10
  publication-title: Lancet
  doi: 10.1016/0140-6736(91)90133-A
– volume: 104
  start-page: 325
  year: 1999
  ident: BF02885420_CR3
  publication-title: American Academy of Pediatrics. Committee on Genetics. Pediatrics
– volume: 92
  start-page: 57
  year: 2000
  ident: BF02885420_CR1
  publication-title: Eur J Obst Gyneco Reprod Biol
  doi: 10.1016/S0301-2115(00)00426-7
– volume: 125
  start-page: 824
  year: 2001
  ident: BF02885420_CR7
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/2001-125-0824-MA
– volume: 15
  start-page: 511
  year: 1998
  ident: BF02885420_CR13
  publication-title: Am J Perinatol
  doi: 10.1055/s-2007-993975
– volume: 55
  start-page: 134
  year: 1997
  ident: BF02885420_CR11
  publication-title: Teratology
  doi: 10.1002/(SICI)1096-9926(199702)55:2<134::AID-TERA3>3.0.CO;2-3
– volume: 249
  start-page: 423
  year: 2001
  ident: BF02885420_CR15
  publication-title: J Intern Med
  doi: 10.1046/j.1365-2796.2001.00819.x
– volume: 106
  start-page: 677
  year: 2000
  ident: BF02885420_CR8
  publication-title: Pediatrics
  doi: 10.1542/peds.106.4.677
– volume: 5
  start-page: 1851
  year: 1996
  ident: BF02885420_CR14
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/5.12.1851
– volume: 18
  start-page: 545
  year: 1998
  ident: BF02885420_CR6
  publication-title: Prenat Diagn
  doi: 10.1002/(SICI)1097-0223(199806)18:6<545::AID-PD293>3.0.CO;2-2
– volume: 73
  start-page: 113
  year: 1997
  ident: BF02885420_CR2
  publication-title: Am J Med Genet
  doi: 10.1002/(SICI)1096-8628(19971212)73:2<113::AID-AJMG2>3.0.CO;2-V
– volume: 1
  start-page: 339
  year: 1980
  ident: BF02885420_CR9
  publication-title: Lancet
  doi: 10.1016/S0140-6736(80)90886-7
– volume: 358
  start-page: 796
  year: 2001
  ident: BF02885420_CR12
  publication-title: Lancet
  doi: 10.1016/S0140-6736(01)05969-4
SSID ssj0057624
ssib031263182
ssj0002039635
ssib051367596
ssib034325102
Score 1.5728317
Snippet To evaluate the implication of methymalonic acid (MMA) in the early diagnosis of neural tube defects (NTD), a quantitative assay for MMA was established by...
R318; To evaluate the implication of methymalonic acid (MMA) in the early diagnosis of neural tube defects (NTD), a quantitative assay for MMA was established...
SourceID wanfang
proquest
pubmed
crossref
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 166
SubjectTerms Adult
Amniotic Fluid - chemistry
Biomarkers - analysis
Biomarkers - urine
Female
Folic Acid - blood
Humans
Methylmalonic Acid - analysis
Methylmalonic Acid - urine
Neural Tube Defects - diagnosis
Neural Tube Defects - metabolism
Pregnancy
Pregnancy Trimester, Second
Prenatal Diagnosis
Vitamin B 12 - blood
尿液检测
早期诊断
甲基丙二酸
神经管缺陷
Title Methylmalonic Acid in Amniotic Fluid and Maternal Urine as a Marker for Neural Tube Defects
URI http://lib.cqvip.com/qk/85740A/20042/9746889.html
https://www.ncbi.nlm.nih.gov/pubmed/15315171
https://www.proquest.com/docview/66792490
https://d.wanfangdata.com.cn/periodical/tjykdxxb-e200402017
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfK9sILAvHVAcMSe0FVpnw4cfLYoVUV6spLKyrxEGzHFlm7FNpGGvvruXOSNlWH-HiJKstyqrtfznfn8-8IOTN425FJiE14ZBymmOckoWaO6wsv0YnSXGGgeDWOhlP2cRbOOp2vraqlciPP1d2990r-R6swBnrFW7L_oNntojAAv0G_8AQNw_OvdHylQcyLG7GwbWyEypFIqSduinyJPKxmUeaWibUHbqnleu5hbl1jbxkBY6u5XtkyQyS1xKLzUuItKlvg8RundViKu2_Ynmi_oKOxEPiuXbL-fHsMVO-zW_99VNoM7SwX9r7WQfZ61ALtZ1011l7u5o3y0tYGiuK6LPbyFqxlZCOOFa8VAUZjhX3WQpvfMqle1ZXlwNS7TQG7H8ch893dhtYc4o8_pYPpaJROLmeTB-TY59xDuzf1-81eDcFW1fa4-Uf7BLb1yki7gaL9AQLZd18OYhJ79aswIKyWlzJ5TB7VmqL9CitPSEcXT8mXPZxQxAnNC9rghFqcUNAdbXBCLU6oWFNBK5xQwAmtcEIRJ7TGyTMyHVxOPgyduqmGo8CZ5w6E2J5hjHEd6oR5GVOGxYn0uYk1N64OslgqBVEyeO4syJRWUrhBrGLXaCYzL3hOjoploV8SGgW-yMJQaRlnzJcmiWITGQ8pR8Erl6ZLTrZyA6dMzZFqLIUANorjpEveN4JMVU1Hj11RFmlDpL1TQJe82879XpGw3DvrbaOPFGwkHnyJQi_LdRpFHNMMMONFpabdKrAFhR73uuSs1ltaf9_rdHP9c57d3spUI3whrPL4yR9f8Yo8rGq7MEn3mhxtVqV-A27rRp6S4_7g4mJ8ahH4CwOQnQ8
linkProvider Springer Nature
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Methylmalonic+acid+in+amniotic+fluid+and+maternal+urine+as+a+marker+for+neural+tube+defects&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Luo%2C+Xiaoping&rft.au=Zhang%2C+Lian&rft.au=Wei%2C+Hong&rft.au=Liu%2C+Wanjun&rft.date=2004&rft.issn=1672-0733&rft.volume=24&rft.issue=2&rft.spage=166&rft_id=info:doi/10.1007%2FBF02885420&rft.externalDBID=NO_FULL_TEXT
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg